Featured Product:
GDm-Health™ is a prescribed digital therapeutic for the management of gestational diabetes (GDM) at home. GDM is typically diagnosed in the third trimester of 5-20% of pregnancies and is associated with complications for mother and child during and after birth.
The GDm-Health™ system enables clinicians to see at a glance up-to-date blood glucose readings for an individual as recorded by patients, whilst simultaneously monitoring larger groups of patients remotely.
This improves care by streamlining communication between midwives and patients, whilst directing attention to those most in need, and importantly freeing up patients and clinicians from unnecessary clinic appointments.
GDm-Health™ has been evaluated in over 1,000 patients at the Royal Berkshire NHS Foundation Trust with transformative results and was launched by Sensyne Health in October 2018.
GDm-Health™ is a prescribed digital therapeutic for the management of gestational diabetes (GDM) at home. GDM is typically diagnosed in the third trimester of 5-20% of pregnancies and is associated with complications for mother and child during and after birth.
The GDm-Health™ system enables clinicians to see at a glance up-to-date blood glucose readings for an individual as recorded by patients, whilst simultaneously monitoring larger groups of patients remotely.
This improves care by streamlining communication between midwives and patients, whilst directing attention to those most in need, and importantly freeing up patients and clinicians from unnecessary clinic appointments.
GDm-Health™ has been evaluated in over 1,000 patients at the Royal Berkshire NHS Foundation Trust with transformative results and was launched by Sensyne Health in October 2018.